• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤微环境中的三级淋巴组织:从其发生到免疫治疗意义。

Tertiary lymphoid tissue in the tumor microenvironment: from its occurrence to immunotherapeutic implications.

机构信息

Department of Immunology and Inflammation, Humanitas Clinical and Research Center , Rozzano, Milan , Italy.

出版信息

Int Rev Immunol. 2015 Mar;34(2):123-33. doi: 10.3109/08830185.2015.1018416.

DOI:10.3109/08830185.2015.1018416
PMID:25901857
Abstract

Recruitment of immune and inflammatory cells in the microenvironment of solid tumors is highly heterogeneous and follows patterns, varying according to the organ of origin and stage of disease, with critical roles in the process of cancer onset and progression. While adaptive cells are endowed with anti-tumor activities, inflammatory components of the immune infiltrate orchestrate an immunosuppressive microenvironment that reveals ambivalent functions of the immune contexture in the tumor milieu. The balance between opposing pro-tumoral and anti-tumoral immune pathways, which occur concomitantly in the tumor microenvironment, and the regulatory networks of these phenomena have been the target of several immunotherapeutic strategies. While the scarcity of adaptive immune effectors in tumors correlates with dismal prognosis, the pathways of activation of tumor-specific lymphocytes are yet to be fully elucidated. Recently, the occurrence of tertiary lymphoid tissue was revealed to be critical in mediating the dynamics of T cell recruitment and local activation of immune cells in the tumor microenvironment. Thus, tertiary lymphoid tissue assessment and targeting emerge as a promising approach for the design of novel prognostic immune signatures and immunotherapeutic strategies. The immunological behavior of tertiary lymphoid tissue, its occurrence in the tumor immune microenvironment and its clinical relevance are discussed here.

摘要

实体瘤微环境中免疫细胞和炎症细胞的募集具有高度异质性,并呈现出模式,根据起源器官和疾病阶段而变化,在癌症发生和进展过程中起着关键作用。虽然适应性细胞具有抗肿瘤活性,但炎症浸润的免疫成分可协调免疫抑制微环境,揭示了肿瘤微环境中免疫结构的双重功能。在肿瘤微环境中同时发生的对立的促肿瘤和抗肿瘤免疫途径之间的平衡,以及这些现象的调节网络,一直是几种免疫治疗策略的目标。虽然肿瘤中适应性免疫效应物的缺乏与预后不良相关,但肿瘤特异性淋巴细胞的激活途径仍有待充分阐明。最近,三级淋巴组织的发生被揭示为在肿瘤微环境中调节 T 细胞募集和局部免疫细胞激活的动力学中起着关键作用。因此,三级淋巴组织的评估和靶向被认为是设计新的预后免疫特征和免疫治疗策略的有前途的方法。本文讨论了三级淋巴组织的免疫学行为、其在肿瘤免疫微环境中的发生及其临床相关性。

相似文献

1
Tertiary lymphoid tissue in the tumor microenvironment: from its occurrence to immunotherapeutic implications.肿瘤微环境中的三级淋巴组织:从其发生到免疫治疗意义。
Int Rev Immunol. 2015 Mar;34(2):123-33. doi: 10.3109/08830185.2015.1018416.
2
Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers.三级淋巴组织的出现与 T 细胞浸润有关,并可预测早期结直肠癌的预后更好。
Clin Cancer Res. 2014 Apr 15;20(8):2147-58. doi: 10.1158/1078-0432.CCR-13-2590. Epub 2014 Feb 12.
3
Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers.三级淋巴结构,人类癌症抗肿瘤反应的推动者。
Immunol Rev. 2016 May;271(1):260-75. doi: 10.1111/imr.12405.
4
Therapeutic Lymphoid Organogenesis in the Tumor Microenvironment.肿瘤微环境中的治疗性淋巴器官发生
Adv Cancer Res. 2015;128:197-233. doi: 10.1016/bs.acr.2015.04.003. Epub 2015 May 5.
5
Trafficking of T cells into tumors.T 细胞向肿瘤的转移。
Cancer Res. 2014 Dec 15;74(24):7168-74. doi: 10.1158/0008-5472.CAN-14-2458. Epub 2014 Dec 4.
6
The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures.癌症免疫监视的连续性:预后、预测和机制特征。
Immunity. 2013 Jul 25;39(1):11-26. doi: 10.1016/j.immuni.2013.07.008.
7
Dendritic cells in the tumor microenvironment: prognostic and theranostic impact.肿瘤微环境中的树突状细胞:预后和治疗诊断影响。
Semin Immunol. 2020 Apr;48:101410. doi: 10.1016/j.smim.2020.101410. Epub 2020 Oct 1.
8
Immune suppressive mechanisms in the tumor microenvironment.肿瘤微环境中的免疫抑制机制。
Curr Opin Immunol. 2016 Apr;39:1-6. doi: 10.1016/j.coi.2015.10.009. Epub 2015 Nov 21.
9
A stressful microenvironment: opposing effects of the endoplasmic reticulum stress response in the suppression and enhancement of adaptive tumor immunity.应激微环境:内质网应激反应在抑制和增强适应性肿瘤免疫中的相反作用。
Int Rev Immunol. 2015 Mar;34(2):104-22. doi: 10.3109/08830185.2015.1018415. Epub 2015 Mar 16.
10
Adoptive T-cell therapy: a need for standard immune monitoring.过继性T细胞疗法:标准免疫监测的必要性
Immunotherapy. 2015;7(5):513-33. doi: 10.2217/imt.15.23.

引用本文的文献

1
Tertiary lymphoid structures in esophageal cancer: a novel target for immunotherapy.食管癌中的三级淋巴结构:免疫治疗的新靶点
Front Immunol. 2025 Jun 4;16:1543322. doi: 10.3389/fimmu.2025.1543322. eCollection 2025.
2
Tertiary lymphoid structures in colorectal cancer - organization and immune cell interactions.结直肠癌中的三级淋巴结构——组织与免疫细胞相互作用
Am J Clin Exp Immunol. 2024 Dec 25;13(6):236-245. doi: 10.62347/GRYY2849. eCollection 2024.
3
Pediatric Solid Cancers: Dissecting the Tumor Microenvironment to Improve the Results of Clinical Immunotherapy.
儿科实体瘤:剖析肿瘤微环境以改善临床免疫治疗效果。
Int J Mol Sci. 2024 Mar 12;25(6):3225. doi: 10.3390/ijms25063225.
4
Tertiary lymphoid structures are critical for cancer prognosis and therapeutic response.三级淋巴结构对癌症预后和治疗反应至关重要。
Front Immunol. 2023 Jan 11;13:1063711. doi: 10.3389/fimmu.2022.1063711. eCollection 2022.
5
Regulative role of the CXCL13-CXCR5 axis in the tumor microenvironment.CXCL13-CXCR5轴在肿瘤微环境中的调节作用。
Precis Clin Med. 2018 Jun;1(1):49-56. doi: 10.1093/pcmedi/pby006. Epub 2018 Jun 12.
6
Does the Microbiota Composition Influence the Efficacy of Colorectal Cancer Immunotherapy?微生物群组成会影响结直肠癌免疫治疗的疗效吗?
Front Oncol. 2022 Apr 8;12:852194. doi: 10.3389/fonc.2022.852194. eCollection 2022.
7
The Immune Landscape of Human Pancreatic Ductal Carcinoma: Key Players, Clinical Implications, and Challenges.人类胰腺导管腺癌的免疫格局:关键因素、临床意义及挑战
Cancers (Basel). 2022 Feb 16;14(4):995. doi: 10.3390/cancers14040995.
8
Circulating CD137+ T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Patients with Cancer.循环 CD137+T 细胞与癌症患者对抗 PD-1 免疫治疗的改善反应相关。
Clin Cancer Res. 2022 Mar 1;28(5):1027-1037. doi: 10.1158/1078-0432.CCR-21-2918.
9
Tertiary lymphoid structure and B-cell-related pathways: A potential target in tumor immunotherapy.三级淋巴结构与B细胞相关通路:肿瘤免疫治疗的潜在靶点
Oncol Lett. 2021 Dec;22(6):836. doi: 10.3892/ol.2021.13097. Epub 2021 Oct 18.
10
Tertiary Lymphoid Structures in Cancer: The Double-Edged Sword Role in Antitumor Immunity and Potential Therapeutic Induction Strategies.癌症中的三级淋巴结构:在抗肿瘤免疫中的双刃剑作用及潜在的治疗诱导策略
Front Immunol. 2021 Jul 29;12:689270. doi: 10.3389/fimmu.2021.689270. eCollection 2021.